WHO projects global cancer cases to hit 35 million annually by 2050
A new WHO report warns that global cancer cases will surge by 77% over the next three decades, with low-income nations facing the highest burden of disease.
The World Health Organization (WHO) has issued a stark warning that global cancer cases could reach 35 million annually by 2050, a 77% increase from 20 million cases in 2022. This projection, based on data from the WHO’s International Agency for Research on Cancer (IARC) and analyses by The Lancet, underscores a rapidly escalating crisis driven by population aging, rising risk factors, and persistent global inequalities in cancer care. The report highlights that the burden will fall disproportionately on low- and middle-income countries, where access to treatment, early detection, and preventive measures remains severely limited.
By 2050, the number of new cancer cases is expected to surge to 35 million, with cancer deaths potentially doubling to over 18 million. The IARC’s Global Cancer Observatory, which tracks data across 185 countries, identifies lung cancer as the most common diagnosis and cause of death, accounting for 12.4% of new cases and 18.7% of deaths in 2022. Breast cancer, while the second most diagnosed, remains a leading cause of mortality, particularly in lower-income regions where survival rates lag far behind those in wealthier nations. In high-income countries, breast cancer survival exceeds 85%, but in low-income settings, it drops to around 40%, according to the WHO.
Key drivers of the projected surge include tobacco use, obesity, alcohol consumption, and environmental pollutants. Despite declines in smoking rates — 27% fewer people smoked in 2024 compared to 2010 — obesity and physical inactivity continue to rise, exacerbating cancer risks. The WHO report emphasizes that nearly 40% of new cancer cases are preventable through lifestyle changes, early screening, and vaccination programs. However, disparities in access to these interventions persist. For instance, only 39% of countries provide minimal cancer treatment, and 45–60% of patients face catastrophic health costs, pushing families into debt or poverty.
The crisis extends beyond diagnosis and treatment to the global cancer workforce. A report published in The Lancet warns that 100 million healthcare workers will be needed by 2050 to meet the growing demand, but a shortfall of 100 million staff, primarily nurses and diagnostic specialists, threatens to overwhelm systems. Currently, one in three cancer cases go undiagnosed, with limited access to basic care in parts of Africa. The WHO’s Director-General, Tedros Adhanom Ghebreyesus, stressed that “whether a person survives cancer should never depend on where they were born or what they earn,” calling for urgent action to bridge these gaps.
Low- and middle-income countries face the steepest increases in cancer incidence, with low-human development index (HDI) nations projected to see a 142% rise in cases by 2050. Cervical cancer, largely preventable through vaccination and screening, remains the eighth most common cancer globally and the ninth leading cause of death, disproportionately affecting women in sub-Saharan Africa. The WHO’s Cervical Cancer Elimination Initiative aims to address this through expanded immunization programs, but progress is hindered by limited funding and infrastructure.
The economic and social toll of the crisis is equally alarming. The WHO estimates that investing in cancer prevention and control yields a $9.50 return for every dollar spent, yet global spending on cancer care remains heavily skewed. The United States, the highest spender at nearly $209 billion in 2020, contrasts sharply with low-income nations where resources are scarce. Meanwhile, the rise in cancer cases is linked to demographic shifts, including an aging population and increased exposure to environmental risks. As life expectancy grows, more people are living long enough to develop cancer, a trend described by researchers as “a demographic shift that demands an equally ambitious response in cancer care.”
Experts urge governments to prioritize cancer control through policy reforms, increased funding, and international collaboration. The Lancet report calls for stronger regulations on carcinogens, expanded access to affordable treatments, and investments in digital health technologies to address workforce shortages. “The future of cancer control depends on decisive, collective action today,” warns Dr. Lisa Force of the Institute for Health Metrics and Evaluation. As the WHO’s projections underscore, the coming decades will test the world’s ability to confront a disease that transcends borders, economies, and individual fates.
